A 3-Week Nonalcoholic Steatohepatitis Mouse Model Allows the Rapid Evaluation of Liraglutide and Elafibranor Benefits on NASH

Metabolism: Clinical and Experimental - Netherlands
doi 10.1016/j.metabol.2019.12.059
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mouse Models of Nonalcoholic Steatohepatitis Towards Optimization of Their Relevance to Human NASH

Hepatology
MedicineHepatology
2019English

Cyclophilin Inhibition as a Potential Treatment for Nonalcoholic Steatohepatitis (NASH)

Expert Opinion on Investigational Drugs
MedicinePharmacology
2019English

A New Method to Induce Nonalcoholic Steatohepatitis (NASH) in Mice

BMC Gastroenterology
MedicineGastroenterology
2019English

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2018English

Antifibrotic Effect of Pirfenidone in a Mouse Model of Human Nonalcoholic Steatohepatitis

Scientific Reports
Multidisciplinary
2017English

Comprehensive Circular RNA Expression Profiles in a Mouse Model of Nonalcoholic Steatohepatitis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis

Hepatology
MedicineHepatology
2017English

Effects of Bezafibrate to High Trans-Fat Diet (HTD) -Induced Nonalcoholic Steatohepatitis (NASH) Model in Mice

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Peroxiredoxin 4 Protects Against Nonalcoholic Steatohepatitis and Type 2 Diabetes in a Nongenetic Mouse Model

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy